
Phase 2 data show RAP-219 eases acute bipolar mania with significant YMRS gains and encouraging tolerability, setting the stage for FDA talks and phase 3 plans.
The top 3 issues in treating bipolar disorder are...
CONFERENCE REPORTER
Mark Jankelow, MSN, PMHNP-BC, shares what he believes are the top challenges in treating bipolar disorder at the Real Psychiatry conference in Scottsdale, AZ. His top issues include (1) lack of insight on the part of the patient, or the patient not realizing they are affected by bipolar disorder, (2) recognizing the difference between unipolar depression and bipolar depression, and (3) keeping patients on their medication.
Mr Jankelow is an experienced board-certified psychiatric nurse practitioner who has worked in community mental health, the Colorado Department of Corrections, and is the owner of a Springbok Health, Inc.

